価格表

在庫・価格 : 2025年04月28日 17時18分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Clusterin, Human, ELISA Kit
データシート
RD194034200R BLMバイオベンダー ラボラトリー
BioVendor Laboratory Medicine, Inc.
1 kit ¥125,000
(未発注)
追加

在庫・価格 : 2025年04月28日 17時18分 現在

Clusterin, Human, ELISA Kit

  • 商品コード:RD194034200R
  • メーカー:BLM
  • 包装:1kit
  • 価格: ¥125,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Stejskal D et al. Evaluation of serum and urine clusterin as a potential tumor marker for urinary bladder cancer. Neoplasma 2006;53(4):343-6
Stejskal D et al
2006/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Urine,Cerebrospinal fluid,Cell lysate PubMed
2 Stejskal D et al. Our experiences with measurement of new potential biomarkers in the diagnosis of latent forms of myocardial ischemia. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2006 Nov;150(2):239-44
Stejskal D et al
2006/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Urine,Cerebrospinal fluid,Cell lysate PubMed
3 Dalrymple A et al. Proteomic profiling of plasma in Huntington's disease reveals neuroinflammatory activation and biomarker candidates. J. Proteome Res. 2007 Jul;6(7):2833-40
Dalrymple A et al
2007/01/01
PubMed
4 Zhang F et al. Alteration in the activation state of new inflammation-associated targets by phospholipase A2-activating protein (PLAA). Cell. Signal. 2008 May;20(5):844-61
Zhang F et al
2008/01/01
PubMed
5 Solichova P et al. Urinary clusterin concentrations--a possible marker of nephropathy? Pilot study. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2007 Dec;151(2):233-6
Solichova P et al
2007/01/01
PubMed
6 Kahnt WD et al. [Determination of GSH-DH activity (E.C.1.8.5.1) presence of the enzyme in different wheat varieties (author's transl)]. Z Lebensm Unters Forsch 1975 Jun;158(2):77-82
Kahnt WD et al
1975/01/01
PubMed
7 Zhang F et al. Phospholipase A2-activating protein (PLAA) enhances cisplatin-induced apoptosis in HeLa cells. Cell. Signal. 2009 Jul;21(7):1085-99
Zhang F et al
2009/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Urine,Cerebrospinal fluid,Cell lysate PubMed
8 Rithidech KN et al. Protein expression profiles in pediatric multiple sclerosis: potential biomarkers. Mult. Scler. 2009 Apr;15(4):455-64
Rithidech KN et al
2009/01/01
PubMed
9 Aguilar-Mahecha A et al. Development of reverse phase protein microarrays for the validation of clusterin, a mid-abundant blood biomarker. Proteome Sci 2009;7:15
Aguilar-Mahecha A et al
2009/01/01
PubMed
10 Vareka I et al. Changes in clusterin serum concentration levels in oncologic patients during the course of spa therapy--a pilot study. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2009 Jun;153(2):117-20
Vareka I et al
2009/01/01
PubMed
11 Miyake H et al. Serum level of clusterin and its density in men with prostate cancer as novel biomarkers reflecting disease extension. Urology 2010 Feb;75(2):454-9
Miyake H et al
2010/01/01
PubMed
12 Banfi C et al. Proteomic analysis of plasma from patients undergoing coronary artery bypass grafting reveals a protease/antiprotease imbalance in favor of the serpin alpha1-antichymotrypsin. J. Proteome Res. 2010 May;9(5):2347-57
Banfi C et al
2010/01/01
PubMed
13 Wang Y et al. Evaluation of serum clusterin as a surveillance tool for human hepatocellular carcinoma with hepatitis B virus related cirrhosis. J. Gastroenterol. Hepatol. 2010 Jun;25(6):1123-8
Wang Y et al
2010/01/01
PubMed
14 Thambisetty M et al. Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease. Arch. Gen. Psychiatry 2010 Jul;67(7):739-48
Thambisetty M et al
2010/01/01
PubMed
15 Chi KN et al. Randomized phase II study of docetaxel and prednisone with or without OGX-011 in patients with metastatic castration-resistant prostate cancer. J. Clin. Oncol. 2010 Sep;28(27):4247-54
Chi KN et al
2010/01/01
PubMed
16 Cubedo J et al. Proteomic signature of Apolipoprotein J in the early phase of new-onset myocardial infarction. J. Proteome Res. 2011 Jan;10(1):211-20
Cubedo J et al
2011/01/01
PubMed
17 Seferovic MD et al. Altered liver secretion of vascular regulatory proteins in hypoxic pregnancies stimulate angiogenesis in vitro. J. Proteome Res. 2011 Apr;10(4):1495-504
Seferovic MD et al
2011/01/01
PubMed
18 Ryan AJ. Traumatic injuries. Office treatment of puncture wounds. Postgrad Med 1976 Aug;60(2):164-8
Ryan AJ
1976/01/01
PubMed
19 Chia S et al. Phase II trial of OGX-011 in combination with docetaxel in metastatic breast cancer. Clin. Cancer Res. 2009 Jan;15(2):708-13
Chia S et al
2009/01/01
PubMed
20 Dukic L et al. The role of human kallikrein 6, clusterin and adiponectin as potential blood biomarkers of dementia. Clin. Biochem. 2016 Feb;49(3):213-8
Dukic L et al
2016/01/01
PubMed
21 Flehmig G et al. Identification of adipokine clusters related to parameters of fat mass, insulin sensitivity and inflammation. PLoS ONE 2014;9(6):e99785
Flehmig G et al
2014/01/01
PubMed
22 Garc鱈a-Rodr鱈guez S et al. Decreased plasma levels of clusterin in patients with psoriasis. Actas Dermosifiliogr ;104(6):497-503
Garc鱈a-Rodr鱈guez S et al
PubMed
23 Kropテ。ト耕ovテ。 T et al. Lower serum clusterin levels in patients with erosive hand osteoarthritis are associated with more pain. BMC Musculoskelet Disord 2018 Jul;19(1):264
Kropテ。ト耕ovテ。 T et al
2018/01/01
PubMed
24 Kwon HS et al. Clusterin expression level correlates with increased oxidative stress in asthmatics. Ann. Allergy Asthma Immunol. 2014 Mar;112(3):217-21
Kwon HS et al
2014/01/01
PubMed
25 Nafee AM et al. Clinical significance of serum clusterin as a biomarker for evaluating diagnosis and metastasis potential of viral-related hepatocellular carcinoma. Clin. Biochem. 2012 Sep;45(13-14):1070-4
Nafee AM et al
2012/01/01
PubMed
26 Riaz MA et al. Clusterin signals via ApoER2/VLDLR and induces meiosis of male germ cells. Am J Transl Res 2017;9(3):1266-1276
Riaz MA et al
2017/01/01
PubMed
27 Rubinow KB et al. Acute sex steroid withdrawal increases cholesterol efflux capacity and HDL-associated clusterin in men. Steroids 2012 Apr;77(5):454-60
Rubinow KB et al
2012/01/01
PubMed
28 Saad F et al. Randomized phase II trial of Custirsen (OGX-011) in combination with docetaxel or mitoxantrone as second-line therapy in patients with metastatic castrate-resistant prostate cancer progressing after first-line docetaxel: CUOG trial P-06c. Cl
Saad F et al
2011/01/01
PubMed
29 Schlatzer D et al. Novel urinary protein biomarkers predicting the development of microalbuminuria and renal function decline in type 1 diabetes. Diabetes Care 2012 Mar;35(3):549-55
Schlatzer D et al
2012/01/01
PubMed
  • No.: 1
  • 文献情報:
    Stejskal D et al. Evaluation of serum and urine clusterin as a potential tumor marker for urinary bladder cancer. Neoplasma 2006;53(4):343-6
    Stejskal D et al
    2006/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Urine,Cerebrospinal fluid,Cell lysate
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Stejskal D et al. Our experiences with measurement of new potential biomarkers in the diagnosis of latent forms of myocardial ischemia. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2006 Nov;150(2):239-44
    Stejskal D et al
    2006/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Urine,Cerebrospinal fluid,Cell lysate
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Dalrymple A et al. Proteomic profiling of plasma in Huntington's disease reveals neuroinflammatory activation and biomarker candidates. J. Proteome Res. 2007 Jul;6(7):2833-40
    Dalrymple A et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Zhang F et al. Alteration in the activation state of new inflammation-associated targets by phospholipase A2-activating protein (PLAA). Cell. Signal. 2008 May;20(5):844-61
    Zhang F et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Solichova P et al. Urinary clusterin concentrations--a possible marker of nephropathy? Pilot study. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2007 Dec;151(2):233-6
    Solichova P et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Kahnt WD et al. [Determination of GSH-DH activity (E.C.1.8.5.1) presence of the enzyme in different wheat varieties (author's transl)]. Z Lebensm Unters Forsch 1975 Jun;158(2):77-82
    Kahnt WD et al
    1975/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Zhang F et al. Phospholipase A2-activating protein (PLAA) enhances cisplatin-induced apoptosis in HeLa cells. Cell. Signal. 2009 Jul;21(7):1085-99
    Zhang F et al
    2009/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate,Urine,Cerebrospinal fluid,Cell lysate
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Rithidech KN et al. Protein expression profiles in pediatric multiple sclerosis: potential biomarkers. Mult. Scler. 2009 Apr;15(4):455-64
    Rithidech KN et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Aguilar-Mahecha A et al. Development of reverse phase protein microarrays for the validation of clusterin, a mid-abundant blood biomarker. Proteome Sci 2009;7:15
    Aguilar-Mahecha A et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Vareka I et al. Changes in clusterin serum concentration levels in oncologic patients during the course of spa therapy--a pilot study. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2009 Jun;153(2):117-20
    Vareka I et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Miyake H et al. Serum level of clusterin and its density in men with prostate cancer as novel biomarkers reflecting disease extension. Urology 2010 Feb;75(2):454-9
    Miyake H et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Banfi C et al. Proteomic analysis of plasma from patients undergoing coronary artery bypass grafting reveals a protease/antiprotease imbalance in favor of the serpin alpha1-antichymotrypsin. J. Proteome Res. 2010 May;9(5):2347-57
    Banfi C et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Wang Y et al. Evaluation of serum clusterin as a surveillance tool for human hepatocellular carcinoma with hepatitis B virus related cirrhosis. J. Gastroenterol. Hepatol. 2010 Jun;25(6):1123-8
    Wang Y et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Thambisetty M et al. Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease. Arch. Gen. Psychiatry 2010 Jul;67(7):739-48
    Thambisetty M et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Chi KN et al. Randomized phase II study of docetaxel and prednisone with or without OGX-011 in patients with metastatic castration-resistant prostate cancer. J. Clin. Oncol. 2010 Sep;28(27):4247-54
    Chi KN et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Cubedo J et al. Proteomic signature of Apolipoprotein J in the early phase of new-onset myocardial infarction. J. Proteome Res. 2011 Jan;10(1):211-20
    Cubedo J et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Seferovic MD et al. Altered liver secretion of vascular regulatory proteins in hypoxic pregnancies stimulate angiogenesis in vitro. J. Proteome Res. 2011 Apr;10(4):1495-504
    Seferovic MD et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Ryan AJ. Traumatic injuries. Office treatment of puncture wounds. Postgrad Med 1976 Aug;60(2):164-8
    Ryan AJ
    1976/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Chia S et al. Phase II trial of OGX-011 in combination with docetaxel in metastatic breast cancer. Clin. Cancer Res. 2009 Jan;15(2):708-13
    Chia S et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Dukic L et al. The role of human kallikrein 6, clusterin and adiponectin as potential blood biomarkers of dementia. Clin. Biochem. 2016 Feb;49(3):213-8
    Dukic L et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Flehmig G et al. Identification of adipokine clusters related to parameters of fat mass, insulin sensitivity and inflammation. PLoS ONE 2014;9(6):e99785
    Flehmig G et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Garc鱈a-Rodr鱈guez S et al. Decreased plasma levels of clusterin in patients with psoriasis. Actas Dermosifiliogr ;104(6):497-503
    Garc鱈a-Rodr鱈guez S et al
  • 備考:
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Kropテ。ト耕ovテ。 T et al. Lower serum clusterin levels in patients with erosive hand osteoarthritis are associated with more pain. BMC Musculoskelet Disord 2018 Jul;19(1):264
    Kropテ。ト耕ovテ。 T et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 24
  • 文献情報:
    Kwon HS et al. Clusterin expression level correlates with increased oxidative stress in asthmatics. Ann. Allergy Asthma Immunol. 2014 Mar;112(3):217-21
    Kwon HS et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 25
  • 文献情報:
    Nafee AM et al. Clinical significance of serum clusterin as a biomarker for evaluating diagnosis and metastasis potential of viral-related hepatocellular carcinoma. Clin. Biochem. 2012 Sep;45(13-14):1070-4
    Nafee AM et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 26
  • 文献情報:
    Riaz MA et al. Clusterin signals via ApoER2/VLDLR and induces meiosis of male germ cells. Am J Transl Res 2017;9(3):1266-1276
    Riaz MA et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 27
  • 文献情報:
    Rubinow KB et al. Acute sex steroid withdrawal increases cholesterol efflux capacity and HDL-associated clusterin in men. Steroids 2012 Apr;77(5):454-60
    Rubinow KB et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 28
  • 文献情報:
    Saad F et al. Randomized phase II trial of Custirsen (OGX-011) in combination with docetaxel or mitoxantrone as second-line therapy in patients with metastatic castrate-resistant prostate cancer progressing after first-line docetaxel: CUOG trial P-06c. Cl
    Saad F et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 29
  • 文献情報:
    Schlatzer D et al. Novel urinary protein biomarkers predicting the development of microalbuminuria and renal function decline in type 1 diabetes. Diabetes Care 2012 Mar;35(3):549-55
    Schlatzer D et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed